Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study

被引:88
作者
Oikonomou, Evangelos [1 ,2 ]
Souvaliotis, Nektarios [1 ]
Lampsas, Stamatios [1 ]
Siasos, Gerasimos [1 ,2 ]
Poulakou, Garyphallia [3 ]
Theofilis, Panagiotis [2 ]
Papaioannou, Theodore G. [2 ]
Haidich, Anna-Bettina [4 ]
Tsaousi, Georgia [5 ,6 ]
Ntousopoulos, Vasileios [3 ]
Sakka, Vissaria [3 ]
Charalambous, Georgios [7 ]
Rapti, Vasiliki [3 ]
Raftopoulou, Sylvia [8 ]
Syrigos, Konstantinos [3 ]
Tsioufis, Costas [2 ]
Tousoulis, Dimitris [2 ]
Vavuranakis, Manolis [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Cardiol 3, Med Sch, Sotiria Chest Dis Hosp, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Dept Cardiol 1, Med Sch, Hippokration Gen Hosp, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Dept Med 3, Sotiria Chest Dis Hosp, Med Sch, Athens, Greece
[4] Aristotle Univ Thessaloniki, Dept Hyg Social Prevent Med & Med Stat, Med Sch, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Med Sch, Dept Anesthesiol, Thessaloniki, Greece
[6] Aristotle Univ Thessaloniki, Med Sch, ICU, Thessaloniki, Greece
[7] Hippokrateion Hosp, Emergency Dept, Athens, Greece
[8] Sotiria Chest Dis Hosp, Intens Care Unit, Athens, Greece
关键词
COVID-19; Flow-mediated dilation; Endothelial function; Endothelium; CELL INFECTION;
D O I
10.1016/j.vph.2022.106975
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Coronavirus disease-19 (COVID-19) is implicated by active endotheliitis, and cardiovascular morbidity. The long-COVID-19 syndrome implications in atherosclerosis have not been elucidated yet. We assessed the immediate, intermediate, and long-term effects of COVID-19 on endothelial function.& nbsp;Methods: In this prospective cohort study, patients hospitalized for COVID-19 at the medical ward or Intensive Care Unit (ICU) were enrolled and followed up to 6 months post-hospital discharge. Medical history and labo-ratory examinations were performed while the endothelial function was assessed by brachial artery flow-mediated dilation (FMD). Comparison with propensity score-matched cohort (control group) was performed at the acute (upon hospital admission) and follow-up (1 and 6 months) stages.& nbsp;Results: Seventy-three patients diagnosed with COVID-19 (37% admitted in ICU) were recruited. FMD was significantly (p < 0.001) impaired in the COVID-19 group (1.65 +/- 2.31%) compared to the control (6.51 +/- 2.91%). ICU-treated subjects presented significantly impaired (p = 0.001) FMD (0.48 +/- 1.01%) compared to those treated in the medical ward (2.33 +/- 2.57%). During hospitalization, FMD was inversely associated with Interleukin-6 and Troponin I (p < 0.05 for all). Although, a significant improvement in FMD was noted during the follow-up (acute: 1.75 +/- 2.19% vs. 1 month: 4.23 +/- 2.02%, vs. 6 months: 5.24 +/- 1.62%; p = 0.001), FMD remained impaired compared to control (6.48 +/- 3.08%) at 1 month (p < 0.001) and 6 months (p = 0.01) post-hospital discharge.& nbsp;Conclusion: COVID-19 patients develop a notable endothelial dysfunction, which is progressively improved over a 6-month follow-up but remains impaired compared to healthy controls subjects. Whether chronic dysregulation of endothelial function following COVID-19 could be accompanied by a residual risk for cardiovascular and thrombotic events merits further research.
引用
收藏
页数:7
相关论文
共 40 条
[1]  
Ambrosino P., BIOMEDICINES, V9
[2]   Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation [J].
Ambrosino, Pasquale ;
Molino, Antonio ;
Calcaterra, Ilenia ;
Formisano, Roberto ;
Stufano, Silvia ;
Spedicato, Giorgio Alfredo ;
Motta, Andrea ;
Papa, Antimo ;
Di Minno, Matteo Nicola Dario ;
Maniscalco, Mauro .
BIOMEDICINES, 2021, 9 (06)
[3]  
[Anonymous], 2021, Obesity
[4]   Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study [J].
Bacchiega, Bruno Cesar ;
Bacchiega, Ana Beatriz ;
Gomez Usnayo, Magali Justina ;
Bedirian, Ricardo ;
Singh, Gurkirpal ;
Castelar Pinheiro, Geraldo da Rocha .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03)
[5]   Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19 [J].
Bianconi, Vanessa ;
Mannarino, Massimo Raffaele ;
Figorilli, Filippo ;
Schiaroli, Elisabetta ;
Cosentini, Elena ;
Batori, Giuseppe ;
Marini, Ettore ;
Sahebkar, Amirhossein ;
Grignani, Francesco ;
Gidari, Anna ;
Francisci, Daniela ;
Pirro, Matteo .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
[6]   Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 [J].
Bonaventura, Aldo ;
Vecchie, Alessandra ;
Dagna, Lorenzo ;
Martinod, Kimberly ;
Dixon, Dave L. ;
Van Tassell, Benjamin W. ;
Dentali, Francesco ;
Montecucco, Fabrizio ;
Massberg, Steffen ;
Levi, Marcel ;
Abbate, Antonio .
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (05) :319-329
[7]   Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) [J].
Cenko, Edina ;
Badimon, Lina ;
Bugiardini, Raffaele ;
Claeys, Marc J. ;
De Luca, Giuseppe ;
de Wit, Cor ;
Derumeaux, Genevieve ;
Dorobantu, Maria ;
Duncker, Dirk J. ;
Eringa, Etto C. ;
Gorog, Diana A. ;
Hassager, Christian ;
Heinzel, Frank R. ;
Huber, Kurt ;
Manfrini, Olivia ;
Milicic, Davor ;
Oikonomou, Evangelos ;
Padro, Teresa ;
Trifunovic-Zamaklar, Danijela ;
Vasiljevic-Pokrajcic, Zorana ;
Vavlukis, Marija ;
Vilahur, Gemma ;
Tousoulis, Dimitris .
CARDIOVASCULAR RESEARCH, 2021, 117 (14) :2705-2729
[8]  
COVID-19, THER TRIAL SYN 2020
[9]   Histopathological observations in COVID-19: a systematic review [J].
Deshmukh, Vishwajit ;
Motwani, Rohini ;
Kumar, Ashutosh ;
Kumari, Chiman ;
Raza, Khursheed .
JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (02) :76-83
[10]  
Diaz J.V., 2021, LANCET INFECT DIS